Skip to main content
Premium Trial:

Request an Annual Quote

Agencourt and Integrated Genomics Sign Co-Marketing Agreement

NEW YORK, Aug. 20 (GenomeWeb News) - Agencourt Bioscience and Integrated Genomics have signed an agreement to co-market their sequencing, bioinformatics, and library construction services, the companies said today.

 

Under the agreement Agencourt, of Beverly, Mass., will provide customers with the library construction and sequencing services, and Integrated Genomics, of Chicago, will provide its genetic analysis software, bioinformatics services, and genome database.

 

The agreement "will allow our customers to make better use of the sequence data we generate by identifying previously unknown or mischaracterized genes, assigning functions to genes and integrating genes into pathways," R. Brian McKernan, president and CEO at Agencourt, said in a statement.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.